Skip to content
Home/Companies/Healthcare/R2I D* SOFTWAY MEDICAL DEVELOPPEMENT
RD

R2I D* SOFTWAY MEDICAL DEVELOPPEMENT

Healthcare·France·Exited 2020·Held 3yr

R2I D* SOFTWAY MEDICAL DEVELOPPEMENT is a healthcare company, headquartered in France.

Entry
2017
Hold
3yr
Exit
2020
Est. EV
–

Who owns R2I D* SOFTWAY MEDICAL DEVELOPPEMENT?

R2I D* SOFTWAY MEDICAL DEVELOPPEMENT was owned by Naxicap Partners through NIO I (2017 vintage) from 2017 to 2020, exited via MBO.

Hand-verified · updated 2026-04-21

Naxicap Partners
Investor
Naxicap Partners
NIO I · 2017 · Buyout

Key facts

HQFrance
SectorHealthcare
Exit Type
MBO
Buyer
–
MOIC
–
Exit Year
2020

More from NIO I

Other portfolio companies in the same fund.

Dental Monitoring
Exited 2021
HealthcareFrance
to
EMERA
Active
HealthcareFrance· 2019
EXECUTIVE IT
Exited 2023
SoftwareFrance· 2019
FINOPHTA
Exited 2019
SoftwareFrance· 2019
to
KEYS ASSET MANAGEMENT
Active
Business ServicesFrance· 2019
MORIA
Active
HealthcareFrance· 2019

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
Active
Advent InternationalUS
Data refreshed weekly · Sourced from public filings